Faculté de Pharmacie

Jan 7, 2025 | link.springer.com | Faculté de Pharmacie |Université Laval |Quebec City

AbstractA positive association between sugar-sweetened beverages (SSBs) and diabetes risk has been shown, with inconsistent evidence between artificially sweetened beverages (ASBs) and diabetes. Moreover, it is uncertain if physical activity can mitigate the negative effects of these beverages on diabetes development. Therefore, we aimed to evaluate the independent and joint associations between SSB or ASB consumption and physical activity on the risk of type 2 diabetes.

Sep 20, 2024 | link.springer.com | Faculté de Pharmacie |Université Laval

AbstractData on associations between adiposity and heart rate variability (HRV) in prepubertal children are limited. We examined the associations between adiposity indices and HRV, independent of lifestyle behaviors, comparing multiple indicators of adiposity, and explored differences between boys and girls. Data stem from 469 participants of the QUALITY cohort (630 children aged 8–10 years with a parental history of obesity).

Jul 10, 2024 | cjhp-online.ca | CHU Sainte-Justine |Faculté de Pharmacie

License After publication of a manuscript in the CJHP, the authors of the manuscript must obtain written permission from the CSHP ([email protected]) before reproducing any text, figures, tables, or illustrations from the work in future works of their own. If a submitted manuscript is declined for publication in the CJHP, all said rights shall revert to the authors.

Dec 7, 2023 | academic.oup.com | Faculté de Pharmacie |Bayer AG

Time-varying confounding is a common challenge for causal inference in observational studies with time-varying treatments, long follow-up periods, and participant dropout. Confounder adjustment using traditional approaches can be limited by data sparsity, weight instability, and computational issues.

Oct 23, 2023 | ashpublications.org | Assistance Publique |Hôpital Saint-Louis |Faculté de Pharmacie

In the European Union, several advanced therapy medicinal products were granted with marketing authorization during the last decades. Despite several withdrawals from use, 18 advanced therapy medicinal products are still authorized as of January 2023.1 Gene therapies are the most represented (68%), especially since the emergence of chimeric antigen receptors (CAR) T cells.